NCT07279584 2025-12-12
Golidocitinib Combined With GemOx in RR PTCL
Ruijin Hospital
Phase 2 Not yet recruiting
Clinical Trials
4 trialsNCT07081607 2025-07-23
Golidocitinib With Azacitidine and Chidamide in Patients With Peripheral T-cell Lymphoma.
Ruijin Hospital
Phase 2 Not yet recruiting
NCT07032532 2025-06-26
Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06702605 2024-11-25
To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma
Evopoint Biosciences Inc.
Phase 2 Not yet recruiting